Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Immunogenic compositions comprising Staphylococcus aureus leukocidin LukA and LukB derived polypeptides

Immunogenic compositions comprising Staphylococcus aureus leukocidin LukA and LukB derived polypeptides

US Patent 11421021 · Granted Aug 23, 2022

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Immunogenic composition comprising a fusion peptide derived from superantigen to2023
Immunogenic composition comprising a fusion peptide derived from superantigen to2023
Immunogenic composition comprising a fusion peptide derived from superantigen to2023
Immunogenic composition comprising a fusion peptide derived from superantigen to2023
Immunogenic composition comprising a fusion peptide derived from superantigen to2022
Immunogenic composition comprising a fusion peptide derived from superantigen to2022
Immunogenic composition comprising a fusion peptide derived from superantigen to2022
Immunogenic composition comprising a fusion peptide derived from superantigen to2022
Broadly neutralizing antibody targeting the ebolavirus glycoprotein internal fus2021
Modified ebolavirus glycoproteins comprising mutations in the head and base doma2021
Targeting immunological functions to the site of bacterial infections using cell2021
Targeting immunological functions to the site of bacterial infections using cell2021